| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
Department of Oncology, Albert Einstein Cancer Center, Bronx, New York 10467
Abstract
Short-chain fatty acids play a critical role in colonic homeostasis because they stimulate pathways of growth arrest, differentiation, and apoptosis. These effects have been well characterized in colonic cell lines in vitro. We investigated the role of ß-catenin-Tcf signaling in these responses to butyrate and other well-characterized inducers of apoptosis of colonic epithelial cells. Unlike wild-type APC, which down-regulates Tcf activity, butyrate, as well as sulindac and trichostatin A, all inducers of G0-G1 cell cycle arrest and apoptosis in the SW620 colonic carcinoma cell line, up-regulate Tcf activity. In contrast, structural analogues of butyrate that do not induce cell cycle arrest or apoptosis and curcumin, which stimulates G2-M arrest without inducing apoptosis, do not alter Tcf activity. Similar to the cell cycle arrest and apoptotic cascade induced by butyrate, the up-regulation of Tcf activity is dependent upon the presence of a mitochondrial membrane potential, unlike the APC-induced down-regulation, which is insensitive to collapse of the mitochondrial membrane potential. Moreover, the butyrate-induced increase in Tcf activity, which is reflected in an increase in ß-catenin-Tcf complex formation, is independent of the down-regulation caused by expression of wild-type APC. Thus, butyrate and wild-type APC have different and independent effects on ß-catenin-Tcf signaling. These data are consistent with other reports that suggest that the absence of wild-type APC, associated with the up-regulation of this signaling pathway, is linked to the probability of a colonic epithelial cell entering an apoptotic cascade.
This article has been cited by other articles:
![]() |
M. Bordonaro, D. L. Lazarova, and A. C. Sartorelli Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells Nucleic Acids Res., May 11, 2004; 32(8): 2660 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Adam, V. Quivy, F. Bex, A. Chariot, Y. Collette, C. Vanhulle, S. Schoonbroodt, V. Goffin, T. L.-A. Nguyen, G. Gloire, et al. Potentiation of Tumor Necrosis Factor-Induced NF-{kappa}B Activation by Deacetylase Inhibitors Is Associated with a Delayed Cytoplasmic Reappearance of I{kappa}B{alpha} Mol. Cell. Biol., September 1, 2003; 23(17): 6200 - 6209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wilson, D. Arango, J. M. Mariadason, B. G. Heerdt, and L. H. Augenlicht TR3/Nur77 in Colon Cancer Cell Apoptosis Cancer Res., September 1, 2003; 63(17): 5401 - 5407. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Augenlicht, A. Velcich, L. Klampfer, J. Huang, G. Corner, M. Aranes, C. Laboisse, B. Rigas, M. Lipkin, K. Yang, et al. Application of Gene Expression Profiling to Colon Cell Maturation, Transformation and Chemoprevention J. Nutr., July 1, 2003; 133(7): 2410S - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Augenlicht, J. M. Mariadason, A. Wilson, D. Arango, W. Yang, B. G. Heerdt, and A. Velcich Short Chain Fatty Acids and Colon Cancer J. Nutr., December 1, 2002; 132(12): 3804S - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wilson, A. Velcich, D. Arango, A. R. Kurland, S. M. Shenoy, R. C. Pezo, J. M. Levsky, R. H. Singer, and L. H. Augenlicht Novel Detection and Differential Utilization of a c-myc Transcriptional Block in Colon Cancer Chemoprevention Cancer Res., November 1, 2002; 62(21): 6006 - 6010. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steinert, M. Wobus, C. Boltze, A. Schutz, M. Wahlbuhl, J. Hamann, and G. Aust Expression and Regulation of CD97 in Colorectal Carcinoma Cell Lines and Tumor Tissues Am. J. Pathol., November 1, 2002; 161(5): 1657 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, A. Velcich, J. Mariadason, C. Nicholas, G. Corner, M. Houston, W. Edelmann, R. Kucherlapati, P. R. Holt, and L. H. Augenlicht p21WAF1/cip1 Is an Important Determinant of Intestinal Cell Response to Sulindac in Vitro and in Vivo Cancer Res., August 1, 2001; 61(16): 6297 - 6302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Heerdt, M. A. Houston, J. M. Mariadason, and L. H. Augenlicht Dissociation of Staurosporine-induced Apoptosis from G2-M Arrest in SW620 Human Colonic Carcinoma Cells: Initiation of the Apoptotic Cascade Is Associated with Elevation of the Mitochondrial Membrane Potential ({{Delta}}{{psi}}m) Cancer Res., December 1, 2000; 60(23): 6704 - 6713. [Abstract] [Full Text] |
||||
![]() |
T. Yamada, A. S. Takaoka, Y. Naishiro, R. Hayashi, K. Maruyama, C. Maesawa, A. Ochiai, and S. Hirohashi Transactivation of the Multidrug Resistance 1 Gene by T-Cell Factor 4/{beta}-Catenin Complex in Early Colorectal Carcinogenesis Cancer Res., September 1, 2000; 60(17): 4761 - 4766. [Abstract] [Full Text] |
||||
![]() |
J. M. Mariadason, G. A. Corner, and L. H. Augenlicht Genetic Reprogramming in Pathways of Colonic Cell Maturation Induced by Short Chain Fatty Acids: Comparison with Trichostatin A, Sulindac, and Curcumin and Implications for Chemoprevention of Colon Cancer Cancer Res., August 1, 2000; 60(16): 4561 - 4572. [Abstract] [Full Text] |
||||
![]() |
C. J. Phiel, F. Zhang, E. Y. Huang, M. G. Guenther, M. A. Lazar, and P. S. Klein Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen J. Biol. Chem., September 21, 2001; 276(39): 36734 - 36741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |